hsv2 dna vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2004 (NCT00274300)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- HSV-2Immunity, active
HSV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hsv2 dna vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04222985 | Phase 1/Phase 2 (Phase 2) | Jan 30, 2020 | Immune Design, Sanofi-Aventis |
| NCT00274300 | Phase 1 | Aug 1, 2004 | PowderMed, The University of Texas, Dallas |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Immune Design | For profit | 1 | 0 | 1 | 2020 |
| PowderMed | For profit | 1 | 1 | 1 | 2004 |
| Sanofi-Aventis | For profit | 1 | 1 | 1 | 2020 |
| The University of Texas, Dallas | Academic/Hospital | 1 | 0 | 1 | 2004 |
4 organizations
Page 1 / 1